IP Library › Granted Patent US 12,540,308
Granted Patent B2
US 12,540,308 · App. 17/628,710 · Granted Feb 3, 2026

Method for mass proliferation of stem cells without using hydrogel

Inventors: Seok Chung (Seoul, KR); Ji Hoon Yang (Seoul, KR); Kyu Hwan Na (Busan, KR); Ye SI Jun (Seoul, KR); Yong Hun Jung (Seoul, KR)
Assignee: NEXT & BIO INC.
C12N5/0602C12M23/12C12N2513/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,540,308
App. No.
17/628,710
Granted
Feb 3, 2026
Kind
B2
Abstract

The present invention provides a stem cell mass proliferation method without using a hydrogel.

Claims (24)

1 . A method of proliferating stem cells, the method comprising:

i) culturing cells, wherein the cultured cells are somatic cells;

ii) preparing a hydrogel-free 3D cell culture plate for producing stem cells;

iii) reprogramming the cultured cells into stem cells in the hydrogel-free 3D cell culture plate;

iv) forming a spheroid of the reprogrammed stem cells;

v) preparing a hydrogel-free 3D cell culture plate for subculturing; and

vi) separating the spheroid into single cells and subculturing the single cells in the hydrogel-free 3D cell culture plate once or more;

wherein the 3D cell culture plate comprises:

a well plate comprising a plurality of main wells and a plurality of sub wells formed at lower portions of the plurality of main wells to be injected with a cell culture solution and comprising recessed parts on a bottom surface thereof; and a connector for high content screening (HCS), which supports the well plate, and

the connector for high content screening (HCS) comprises a base equipped with a fixing means so as to be attached to and detached from a lower end of the well plate and a cover positioned on an upper portion of the well plate to be coupled to the base,

each of the plurality of main wells has a step and includes a space part between the step and each of the plurality of sub wells; and each of the plurality of sub wells has an inclined surface formed so as to taper toward the recessed parts;

each of the plurality of sub wells has an upper end diameter ranging from 3.0 mm to 4.5 mm, the recessed parts have an upper end diameter ranging from 0.45 mm to 1.5 mm, and a ratio of the diameter of each of the plurality of sub wells to the diameter of the recessed parts ranges from 1:0.1 to 1:0.5;

the step has an inclination angle (θ1) ranging from 10° to 60° with respect to a wall of each of the plurality of main wells; and

the inclined surface (θ2) between each of the plurality of sub wells and the recessed parts ranges from 40° to 50°.

2 . The method of claim 1 , wherein the stem cells are one or more selected from the group consisting of adult stem cells, mesenchymal stem cells, adipose-derived stem cells, hematopoietic stem cells, and cord blood stem cells.

3 . The method of claim 1 , wherein the subculturing is subculturing for 1 to 20 generations.

4 . The method of claim 1 , wherein the main well has an individual volume ranging from 100 to 300 μl,

the recessed parts have an individual volume ranging from 20 μl to 50 μl, and

an individual volume ratio of each of the plurality of main wells to the recessed parts is 1:0.1 to 1:0.5 on average.

5 . The method of claim 1 , wherein

the space part has a height (a h ) ranging from 2.0 to 3.0 mm on average,

each of the plurality of sub wells has a height (b h ) ranging from 1.0 to 2.0 mm on average, and

a height ratio (a h :b h ) of the space part to each of the plurality of sub wells ranges from 1:0.3 to 1:1.

6 . The method of claim 1 , wherein the somatic cells are seeded in each of the plurality of sub wells of the cell culture plate at 100 to 1000 cells/well.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 20, 2022
From: CHUNG, SEOK; YANG, JI HOON; NA, KYU HWAN; JUN, YE SI; JUNG, YONG HUN
To: NEXT & BIO INC.
Reel/Frame 058709/0879 →
Continuity (1)
Related Publication 20220275328A1 · Sep 1, 2022
References Cited (95)
US 7767154B2 · Nichols et al. · 2010 [cited by applicant]
US 8642339B2 · Sato et al. · 2014 [cited by applicant]
US 9922421B1 · Degani · 2018 [cited by applicant]
US 20090010507A1 · Geng · 2009 [cited by applicant]
US 20100221768A1 · Akai et al. · 2010 [cited by applicant]
US 20110003389A1 · Nakazawa et al. · 2011 [cited by applicant]
US 20110311144A1 · Tardif · 2011 [cited by applicant]
US 20130135292A1 · Lee · 2013 [cited by applicant]
US 20130174287A1 · Higuera · 2013 [cited by applicant]
US 20150232673A1 · Jing · 2015 [cited by applicant]
US 20170081625A1 · Wikswo · 2017 [cited by applicant]
US 20170253844A1 · Fang et al. · 2017 [cited by applicant]
US 20180187136A1 · Lichtenberg et al. · 2018 [cited by applicant]
US 20180255240A1 · Kato · 2018 [cited by applicant]
US 20190001046A1 · Matheu · 2019 [cited by applicant]
US 20190194611A1 · Jo et al. · 2019 [cited by applicant]
US 20190258846A1 · Dinov · 2019 [cited by applicant]
US 20200017811A1 · Apfel · 2020 [cited by applicant]
US 20200217462A1 · Mitsuzuka · 2020 [cited by applicant]
US 20200300750A1 · Eshel · 2020 [cited by applicant]
US 20210272378A1 · Stomakhin · 2021 [cited by applicant]
US 20220154140A1 · Chung et al. · 2022 [cited by applicant]
US 20220275328A1 · Chung et al. · 2022 [cited by applicant]
CN 102257123A · 2011 [cited by applicant]
CN 106459925A · 2017 [cited by applicant]
CN 108456642A · 2018 [cited by applicant]
CN 111337775A · 2020 [cited by applicant]
EP 2173853B1 · 2010 [cited by applicant]
EP 3150704A1 · 2017 [cited by applicant]
EP 3129144B1 · 2019 [cited by applicant]
JP 2011167101A · 2011 [cited by applicant]
JP 2012157267A · 2012 [cited by applicant]
JP 2017506066A · 2017 [cited by applicant]
KR 2019790001973Y1 · 1979 [cited by applicant]
KR 20130013537A · 2013 [cited by applicant]
KR 20140113139A · 2014 [cited by applicant]
KR 20160017036A · 2016 [cited by applicant]
KR 20160115764A · 2016 [cited by applicant]
KR 20170003177A · 2017 [cited by applicant]
KR 20170010857A · 2017 [cited by applicant]
KR 20170040442A · 2017 [cited by applicant]
KR 20170056241A · 2017 [cited by applicant]
KR 20170073696A · 2017 [cited by applicant]
KR 20180115236A · 2018 [cited by applicant]
KR 20180136410A · 2018 [cited by applicant]
KR 20200081295A · 2019 [cited by applicant]
KR 20200081294A · 2020 [cited by applicant]
WO 2013047655A1 · 2013 [cited by applicant]
WO 2014196204A1 · 2014 [cited by applicant]
WO 2015182159A · 2015 [cited by applicant]
WO 2015182159A1 · 2015 [cited by applicant]
WO 2016069917A1 · 2016 [cited by applicant]
WO 2016103002A1 · 2016 [cited by applicant]
WO 2016203748A1 · 2016 [cited by applicant]
WO 2017060884A1 · 2017 [cited by applicant]
WO 2018011558A1 · 2018 [cited by applicant]
WO 2018196472A1 · 2018 [cited by applicant]
WO 2019145847A1 · 2019 [cited by applicant]
WO 2019203255A1 · 2019 [cited by applicant]
Kazutoshi Takahashi et al. “Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors”, Cell, vol. 126, p. 663-676, Aug. 25, 2006. [cited by applicant]
Kazutoshi Takahashi et al. “Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors”, Cell, vol. 131, p. 861-872, Nov. 30, 2007. [cited by applicant]
Yuguo Lei et al. “A fully defined and scalable 3D culture system for human pluripotent stem cell expansion and differentiation”, PNAs, p. E5039-E5048, published online Nov. 18, 2013; accessed at www.pnas.org/cgi/doi/10.… [cited by applicant]
M. Lancaster et al. “Generation of cerebral organoids from human pluripotent stem cells”, Natural Protocols, vol. 9, No. 10, p. 2329-2340, Sep. 4, 2014. [cited by applicant]
International Search Report for PCT/KR2020/008242 mailed Mar. 24, 2021 (6 pages). [cited by applicant]
International Search Report for PCT/KR2020/008271 mailed Mar. 23, 2021 (5 pages). [cited by applicant]
International Search Report for PCT/KR2020/008274 mailed Mar. 23, 2021 (7 pages). [cited by applicant]
International Search Report for PCT/KR2020/008280 mailed Mar. 24, 2021 (6 pages). [cited by applicant]
International Search Report for PCT/KR2020/008285 mailed Mar. 24, 2021 (6 pages). [cited by applicant]
European Search Report (ESR) for EP Pat. App. 20941637.9 mailed Feb. 26, 2024 (17 pages). [cited by applicant]
English translation of JP Office Action (“JP OA”) for JP Pat. App. 2023-053903 mailed May 7, 2024 (4 pages). [cited by applicant]
English translation of JP Office Action (“JP OA”) for JP Pat. App. 2022-580485 mailed May 21, 2024 (3 pages). [cited by applicant]
English translation of CN Office Action (“CN OA”) for CN Pat. App. 202080057825.0 mailed Nov. 29, 2024 (9 pages). [cited by applicant]
English translation of JP Office Action (“JP OA”) for JP Pat. App. 2022-58053 mailed Jul. 2, 2024 (4 pages). [cited by applicant]
English translation of JP Office Action (“JP OA”) for JP Pat. App. 2022-580506 mailed Mar. 12, 2024 (5 pages). [cited by applicant]
English translation of JP Office Action (“JP OA”) for JP Pat. App. 2022-580503 mailed Jan. 7, 2025 (2 pages). [cited by applicant]
Non-Final Office Action (NFOA) for U.S. Appl. No. 17/628,719, mailed Mar. 3, 2025 (16 pages). [cited by applicant]
Anonymous: “GravityPLUS(TM) Hanging” Dec. 31, 2015. [cited by applicant]
Sebastien Sart et al. “Three-Dimensional Aggregates”, Tissue Engineering Part B, vol. 20, No. 5 (Oct. 1, 2014) p. 365-380. [cited by applicant]
Mark D Ungrin et al. “Rational bioprocess design” Biotechnology and Bioengineering, John Wiley, Hoboken USA vol. 109, No. 4, p. 853-866 (Dec. 2, 2011). [cited by applicant]
Tomomi G. Otsuji et al. “A 3D Sphere Culture System” Stem Cell Reports, vol. 2, No. 5. p. 734-745 (May 1, 2014). [cited by applicant]
Screen Application Note vol. 2, Jun. 2017, URL <http://screen-cell3imager.com/assets/pdf/application/rm/rm-4.pdf>, Searched on May 14, 2024. [cited by applicant]
Apr. 7, 2025 Non-Final Rejection issued in U.S. Appl. No. 17/629,034. [cited by applicant]
Amin ND, Pasca SP. Building Models of Brain Disorders with Three-Dimensional Organoids. Neuron. Oct. 24, 2018; 100 (2):389-405. [cited by applicant]
Comley, John. “Spheroids.” Drug Discovery (2017): 31. [cited by applicant]
Lancaster MA, Renner M, Martin CA, Wenzel D, Bicknell LS, Hurles ME, Homfray T, Penninger JM, Jackson AP, Knoblich JA. Cerebral organoids model human brain development and microcephaly. Nature. Sep. 19, 2013;501 (7467):… [cited by applicant]
Non-Final Office Action Issued on Aug. 13, 2025 in Related U.S. Appl. No. 18/577,140 (11 Pages). [cited by applicant]
Non-Final Office Action Issued on Aug. 26, 2025 in Related U.S. Appl. No. 17/628,719 (17 Pages). [cited by applicant]
Wayne Lewis “Artificial Intelligence Converts 2D Images Into 3D Using Deep Learning” [Video]. SciTech Daily. Nov. 9, 2019 (9 pages). [cited by applicant]
Kh Tohidul Islam et al., “A deep learning based framework for the registration of three dimensional multi-modal medical images of the head.” Scientific Reports. Jan. 21, 2021 (13 pages). [cited by applicant]
Chinese Office Action dated Mar. 8, 2024 (First Page Translation). [cited by applicant]
Chung, Seok, Ji Hoon Yang, Kyu Hwan Na, Yong Hun Jung “Brain Organoid Manufacturing Method”. U.S. Appl. No. 17/629,034, filed Jan. 21, 2022 (Year: 2022). [cited by applicant]
Written Opinion (WO) for PCT/KR2021/095129 mailed Apr. 8, 2022 (8 pages). [cited by applicant]
Non-Final Office Action Issued for U.S. Appl. No. 18/155,985 on Sep. 11, 2025 (16 Pages). [cited by applicant]
Non-Final Office Action issued in U.S. Appl. No. 18/577,155 on Sep. 11, 2025 (22 Pages). [cited by applicant]
Non-Final Office Action Issued in Corresponding U.S. Appl. No. 17/628,719 on May 12, 2025 (32 Pages). [cited by applicant]